HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Bianchi Selected Research

Hypersensitivity (Allergy)

11/2021Use of self-applied sculptured gel nails may increase the risk of allergy to (meth)acrylates in children and adolescents.
1/2012Tetanus toxoid IgE may be useful in predicting allergy during childhood.
10/2011Specific immunotherapy in children: the evidence.
12/2002Allergic cholestatic hepatitis and exanthema induced by metamizole: verification by lymphocyte transformation test.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Bianchi Research Topics

Disease

34Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 07/2003
14Chronic Obstructive Pulmonary Disease (COPD)
10/2015 - 03/2000
8Hidradenitis Suppurativa
07/2021 - 01/2019
7Atopic Dermatitis (Atopic Eczema)
07/2023 - 01/2019
7Psoriatic Arthritis
03/2022 - 02/2017
7Hepatocellular Carcinoma (Hepatoma)
09/2010 - 01/2000
5Necrosis
01/2021 - 11/2008
4COVID-19
08/2022 - 12/2020
4Hypersensitivity (Allergy)
11/2021 - 12/2002
4Infections
02/2018 - 07/2000
4Inflammation (Inflammations)
03/2016 - 08/2004
3Pain (Aches)
01/2021 - 01/2009
3Obesity
11/2019 - 07/2016
3Hypercapnia
10/2017 - 09/2000
3Neoplasms (Cancer)
03/2016 - 05/2001
3Body Weight (Weight, Body)
12/2014 - 07/2013
3Insulin Resistance
12/2014 - 11/2000
3Respiratory Insufficiency (Respiratory Failure)
02/2009 - 06/2000
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2022 - 07/2016
2Eczema
08/2022 - 01/2020
2Basal Cell Carcinoma (Rodent Ulcer)
12/2021 - 07/2004
2Abscess
01/2021 - 06/2020
2Exanthema (Rash)
01/2020 - 12/2002
2Arthralgia (Joint Pain)
06/2017 - 12/2016
2Respiratory Tract Infections (Respiratory Tract Infection)
06/2017 - 12/2016
2Nasopharyngitis
06/2017 - 12/2016
2Headache (Headaches)
06/2017 - 12/2016
2Overweight
02/2017 - 07/2013
2Schizophrenia (Dementia Praecox)
11/2015 - 07/2015
2Melanoma (Melanoma, Malignant)
02/2009 - 08/2001
2Neoplasm Metastasis (Metastasis)
01/2009 - 04/2007
2Glioma (Gliomas)
01/2004 - 01/2000
2Hepatitis
12/2002 - 09/2001
2Pulmonary Heart Disease (Cor Pulmonale)
05/2002 - 08/2000
2Chronic Hepatitis C
10/2001 - 07/2000
2Schistosomiasis (Bilharziasis)
09/2001 - 07/2000
2Lipodystrophy
02/2001 - 11/2000
2Hyperthermia
12/2000 - 01/2000
2Colitis
07/2000 - 04/2000
1Alopecia Areata
12/2023
1Granuloma Annulare
12/2021

Drug/Important Bio-Agent (IBA)

9Adalimumab (Humira)FDA Link
01/2021 - 01/2014
7Monoclonal AntibodiesIBA
07/2023 - 06/2001
6secukinumabIBA
07/2021 - 09/2018
6Proteins (Proteins, Gene)FDA Link
07/2016 - 08/2001
6GasesIBA
09/2005 - 03/2000
6Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2002 - 03/2000
5Glucose (Dextrose)FDA LinkGeneric
05/2020 - 01/2000
5Interleukin-17 (Interleukin 17)IBA
01/2020 - 06/2017
5Biomarkers (Surrogate Marker)IBA
07/2016 - 10/2007
5TaurineFDA Link
01/2004 - 01/2000
4ixekizumabIBA
01/2023 - 01/2019
4dupilumabIBA
08/2022 - 08/2020
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 04/2014
4brodalumabIBA
01/2021 - 12/2016
4Ustekinumab (CNTO 1275)FDA Link
01/2020 - 08/2017
4CytokinesIBA
11/2019 - 09/2001
4LipidsIBA
12/2014 - 06/2011
4gamma-Aminobutyric Acid (GABA)IBA
01/2004 - 01/2000
3apremilastIBA
03/2022 - 03/2017
3AutoantibodiesIBA
01/2020 - 04/2012
3Interleukin-6 (Interleukin 6)IBA
12/2014 - 01/2014
3Oxygen (Dioxygen)IBA
12/2011 - 07/2001
3tazarotene (Tazorac)FDA Link
07/2004 - 07/2003
2risankizumabIBA
02/2022 - 03/2021
2Biosimilar PharmaceuticalsIBA
01/2021 - 12/2017
2Rifampin (Rifampicin)FDA LinkGeneric
01/2021 - 01/2019
2Interleukin-23 (Interleukin 23)IBA
11/2019 - 07/2018
2etanercept biosimilar SB4IBA
11/2019 - 01/2019
2InterleukinsIBA
11/2019 - 07/2018
2Insulin (Novolin)FDA Link
10/2019 - 12/2014
2Interleukin-22 (IL-22)IBA
07/2018 - 01/2014
2Infliximab (Remicade)FDA Link
12/2017 - 01/2014
2Carbon DioxideIBA
10/2017 - 09/2000
2Complement System Proteins (Complement)IBA
10/2015 - 05/2013
2AdiponectinIBA
12/2014 - 07/2013
2C-Reactive ProteinIBA
12/2014 - 04/2014
2Ethanol (Ethyl Alcohol)IBA
11/2006 - 05/2001
2Glutamic Acid (Glutamate)FDA Link
01/2004 - 01/2000
2Aspartic Acid (Aspartate)FDA Link
01/2004 - 01/2000
2Amino AcidsFDA Link
01/2004 - 01/2000
2prednylidene (Pred)IBA
05/2002 - 05/2002
2Human immunodeficiency virus 1 p16 proteaseIBA
02/2001 - 11/2000
2Protease Inhibitors (Protease Inhibitor)IBA
02/2001 - 11/2000
2Reverse Transcriptase InhibitorsIBA
02/2001 - 11/2000
2NucleosidesIBA
02/2001 - 11/2000
2RNA (Ribonucleic Acid)IBA
11/2000 - 07/2000
1baricitinibIBA
12/2023
1Interleukin-13IBA
07/2023
1tralokinumabIBA
07/2023
1tildrakizumabIBA
10/2022
1Phosphodiesterase 4 InhibitorsIBA
03/2022
1HhAntag691IBA
12/2021

Therapy/Procedure

15Therapeutics
03/2022 - 04/2000
5Biological Therapy
12/2020 - 02/2017
5Artificial Respiration (Mechanical Ventilation)
12/2011 - 06/2000
4Liver Transplantation
09/2010 - 07/2000
3Interactive Ventilatory Support
05/2002 - 06/2000
2Aftercare (After-Treatment)
07/2015 - 11/2006
2Catheters
09/2001 - 01/2000